Open company graph database — free web & API
Login

Eisai Australia Pty. Ltd.

エーザイ オーストラリア Pty. Ltd.Alias
Ticker
—
Listed market
—
Country
Australia
Employees (non-consolidated)
—
Related companies
0
§01

Basic information

BASIC
Head office
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

2 DOMAINS
§03

Business

0
§04

Related companies

0 COMPANIES

—

§05

Network

NETWORK
Drag to move · click to open
§06

History

14 EVENTS

Toyoji Naito founded the Sakuragaoka Lab in 1936, helping to usher in a new phase in Japanese drug innovation.Sources

The Sakuragaoka Lab created a string of hits starting with its 1938 launch of Japan's first commercial vitamin E product, which was developed from wheat germ oil extract.Sources

In 1941 Nihon Eisai Co., Ltd., Eisai Co., Ltd.'s immediate predecessor was established in Saitama, eastern Japan.Sources

By 1944 had merged with the lab in Sakuragaoka under the name Nihon Eisai Co., Ltd.Sources

In 1955, the company changed its name from Nihon Eisai Co., Ltd. to Eisai Co., Ltd., as it is known today.Sources

In 1957, with the aim of making another dramatic leap forward, Eisai rolled-out its first 3 year mid term plan.Sources

In the 1970s public awareness of health and safety was increasing in Japan and vitamin E attracted much attention. It was against this backdrop that Eisai introduced its vitamin E product to the market in 1977.Sources

In 1981, as the first step of the company's business expansion into the United States, Eisai established a local subsidiary, Eisai U.S.A. Inc., in suburban Los Angeles.Sources

In 1987, as the Japanese bubble economy inflated and internationalisation became the latest buzzword, Eisai set its sights on breaking into the world's top 20 pharmaceutical companies.Sources

Upon breaking into the world's top 20 pharmaceutical companies at the start of the 21st century, Eisai's global business made another dramatic leap forward propelled by stellar contributions from product sales, with its overseas sales ratio in 2002 exceeding 50% for the first time.Sources

From 2008 to 2010, with the aim of enabling the exchange of knowledge among its researchers to further accelerate drug innovation Eisai established a network of knowledge centres in Tsukuba, the UK, India, and Tokyo.Sources

In June 2009 the EMEA Knowledge Centre was completed in Hatfield in the UK. The centre maintains its own research division, as well as a production division—Eisai's first production base in Europe—and marketing division to effectively oversee all Eisai operations in Europe. The centre combines all pharmaceutical business functions, from drug discovery to sales in one location for the first time in the Group's history, realising a longstanding dream of the company's founder, Toyoji Naito.Sources

In 2014, Eisai expanded into Australia, opening our office in June.Sources

In 2020 New Zealand operations commenced.Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑